Zabka Group S.A. (ZAB)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 31.73 |
|---|---|
| 52-week range | 19.92 – 33.88 |
| Return, 1 month / 3 months | +0.5% / −4.8% |
| Return, 1 year / 3 years | +48.2% / – |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -17.2% |
| Average daily value traded | 120.69M PLN |
| Dividend yield | 7.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zabka Group operates a chain of small convenience stores in Poland, serving customers who want quick everyday shopping close to home. The shops stock groceries, snacks, drinks and ready-to-eat food, and most are run by independent franchisees under the company's brand and operating model. The group is based in Poland and focuses on busy urban and residential neighbourhoods, where customers visit for fast, convenient purchases rather than full weekly grocery trips.
On this site Zabka Group S.A. appears as a stock on the Warsaw Stock Exchange (Poland), code ZAB, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zabka Group S.A. (ZAB) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 31.73 on 22 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 31 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 48.2% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.6% | ||
| From 52-week high | -6.2% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -4.8% | ||
| 6-month return | 29.5% | ||
| 12-month return, skipping the last month | 47.4% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.2% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 120.69M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 7.2% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.0% |
|---|---|
| 1 month | +0.5% |
| 3 months | −4.8% |
| 6 months | +29.5% |
| 1 year | +48.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 31.56 / 26.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jul 2026 | EUR 0.5242 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.